# LGL Group Inc: financial statements, quarterly LGL · NYSE · CIK 61004 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/lgl.md) · [Financials](/companies/lgl/financials.md) · [Filings](/companies/lgl/filings.md) · [Insiders](/companies/lgl/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lgl/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [438](/filings/0001437749-25-010246.md) | [446](/filings/0001437749-25-010246.md) | [392](/filings/0001437749-26-010362.md) | [531](/filings/0001437749-26-010362.md) | [650](/filings/0001437749-26-010362.md) | [653](/filings/0001437749-26-010362.md) | [498](/filings/0001437749-26-016146.md) | [491](/filings/0001437749-26-028064.md) | [661](/filings/0001437749-26-010362.md) | [803](/filings/0001437749-26-010362.md) | [682](/filings/0001437749-26-016146.md) | [750](/filings/0001437749-26-028064.md) | | Operating income | $k | not reported | not reported | [79.0](/filings/0001437749-25-017244.md) | [237](/filings/0001437749-25-026961.md) | [138](/filings/0001437749-25-035205.md) | [245 d](/filings/0001437749-26-010362.md) | [41.0](/filings/0001437749-26-016146.md) | [(31.0)](/filings/0001437749-26-028064.md) | [120](/filings/0001437749-25-035205.md) | [119 d](/filings/0001437749-26-010362.md) | [(785)](/filings/0001437749-26-016146.md) | [(447)](/filings/0001437749-26-028064.md) | | Interest expense | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Income tax | $k | [69.0](/filings/0001437749-25-010246.md) | [169](/filings/0001437749-25-010246.md) | [36.0](/filings/0001437749-26-010362.md) | [76.0](/filings/0001437749-26-010362.md) | [48.0](/filings/0001437749-26-010362.md) | [17.0](/filings/0001437749-26-010362.md) | [28.0](/filings/0001437749-26-016146.md) | [14.0](/filings/0001437749-26-028064.md) | [(674)](/filings/0001437749-26-010362.md) | [126](/filings/0001437749-26-010362.md) | [(180)](/filings/0001437749-26-016146.md) | [(95.0)](/filings/0001437749-26-028064.md) | | Net income | $k | [108](/filings/0001437749-25-010246.md) | [134](/filings/0001437749-25-010246.md) | [21.0](/filings/0001437749-26-010362.md) | [137](/filings/0001437749-26-010362.md) | [72.0](/filings/0001437749-26-010362.md) | [202](/filings/0001437749-26-010362.md) | [(6.0)](/filings/0001437749-26-016146.md) | [(51.0)](/filings/0001437749-26-028064.md) | [772](/filings/0001437749-26-010362.md) | [(27.0)](/filings/0001437749-26-010362.md) | [(622)](/filings/0001437749-26-016146.md) | [(353)](/filings/0001437749-26-028064.md) | | Diluted EPS | $ per share | [0.02](/filings/0001437749-25-010246.md) | [0.02](/filings/0001437749-25-010246.md) | [0.00](/filings/0001437749-26-010362.md) | [0.02](/filings/0001437749-26-010362.md) | [0.01](/filings/0001437749-26-010362.md) | [0.04](/filings/0001437749-26-010362.md) | [0.00](/filings/0001437749-26-016146.md) | [(0.01)](/filings/0001437749-26-028064.md) | [0.14](/filings/0001437749-26-010362.md) | [0.00](/filings/0001437749-26-010362.md) | [(0.10)](/filings/0001437749-26-016146.md) | [(0.06)](/filings/0001437749-26-028064.md) | | Basic EPS | $ per share | [0.02](/filings/0001437749-25-010246.md) | [0.03](/filings/0001437749-25-010246.md) | [0.00](/filings/0001437749-26-010362.md) | [0.03](/filings/0001437749-26-010362.md) | [0.01](/filings/0001437749-26-010362.md) | [0.04](/filings/0001437749-26-010362.md) | [0.00](/filings/0001437749-26-016146.md) | [(0.01)](/filings/0001437749-26-028064.md) | [0.15](/filings/0001437749-26-010362.md) | [0.00](/filings/0001437749-26-010362.md) | [(0.10)](/filings/0001437749-26-016146.md) | [(0.06)](/filings/0001437749-26-028064.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: not reported - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [40.8](/filings/0001437749-23-032026.md) | [40.7](/filings/0001437749-25-010246.md) | [40.9](/filings/0001437749-24-017094.md) | [41.1](/filings/0001437749-24-026400.md) | [41.6](/filings/0001437749-24-034944.md) | [41.6](/filings/0001437749-26-010362.md) | [41.9](/filings/0001437749-25-017244.md) | [41.7](/filings/0001437749-25-026961.md) | [41.6](/filings/0001437749-25-035205.md) | [41.5](/filings/0001437749-26-028064.md) | [46.6](/filings/0001437749-26-016146.md) | [45.1](/filings/0001437749-26-028064.md) | | Current assets | $m | [41.5](/filings/0001437749-23-032026.md) | [41.6](/filings/0001437749-25-010246.md) | [41.7](/filings/0001437749-24-017094.md) | [42.0](/filings/0001437749-24-026400.md) | [42.3](/filings/0001437749-24-034944.md) | [42.6](/filings/0001437749-26-010362.md) | [42.8](/filings/0001437749-25-017244.md) | [42.5](/filings/0001437749-25-026961.md) | [42.8](/filings/0001437749-25-035205.md) | [46.3](/filings/0001437749-26-028064.md) | [47.5](/filings/0001437749-26-016146.md) | [47.0](/filings/0001437749-26-028064.md) | | Total assets | $m | [41.8](/filings/0001437749-23-032026.md) | [41.9](/filings/0001437749-25-010246.md) | [42.0](/filings/0001437749-24-017094.md) | [42.2](/filings/0001437749-24-026400.md) | [42.5](/filings/0001437749-24-034944.md) | [43.1](/filings/0001437749-26-010362.md) | [43.3](/filings/0001437749-25-017244.md) | [43.0](/filings/0001437749-25-026961.md) | [43.3](/filings/0001437749-25-035205.md) | [46.8](/filings/0001437749-26-028064.md) | [48.1](/filings/0001437749-26-016146.md) | [49.7](/filings/0001437749-26-028064.md) | | Current liabilities | $m | [0.6](/filings/0001437749-23-032026.md) | [0.5](/filings/0001437749-25-010246.md) | [0.5](/filings/0001437749-24-017094.md) | [0.6](/filings/0001437749-24-026400.md) | [0.7](/filings/0001437749-24-034944.md) | [0.9](/filings/0001437749-26-010362.md) | [1.0](/filings/0001437749-25-017244.md) | [0.9](/filings/0001437749-25-026961.md) | [1.1](/filings/0001437749-25-035205.md) | [0.9](/filings/0001437749-26-028064.md) | [1.2](/filings/0001437749-26-016146.md) | [1.8](/filings/0001437749-26-028064.md) | | Total liabilities | $m | [1.3](/filings/0001437749-23-032026.md) | [1.2](/filings/0001437749-25-010246.md) | [1.2](/filings/0001437749-24-017094.md) | [1.3](/filings/0001437749-24-026400.md) | [1.5](/filings/0001437749-24-034944.md) | [1.9](/filings/0001437749-26-010362.md) | [2.0](/filings/0001437749-25-017244.md) | [1.9](/filings/0001437749-25-026961.md) | [1.4](/filings/0001437749-25-035205.md) | [1.2](/filings/0001437749-26-028064.md) | [1.5](/filings/0001437749-26-016146.md) | [2.1](/filings/0001437749-26-028064.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [38.6](/filings/0001437749-23-032026.md) | [38.8](/filings/0001437749-25-010246.md) | [38.8](/filings/0001437749-24-017094.md) | [38.9](/filings/0001437749-24-026400.md) | [39.0](/filings/0001437749-24-034944.md) | [39.2](/filings/0001437749-26-010362.md) | [39.2](/filings/0001437749-25-017244.md) | [39.1](/filings/0001437749-25-026961.md) | [39.8](/filings/0001437749-25-035205.md) | [43.5](/filings/0001437749-26-028064.md) | [44.5](/filings/0001437749-26-016146.md) | [44.3](/filings/0001437749-26-028064.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [463 d](/filings/0001437749-24-034944.md) | [(69.0) d](/filings/0001437749-25-010246.md) | [160](/filings/0001437749-25-017244.md) | [203 d](/filings/0001437749-25-026961.md) | [528 d](/filings/0001437749-25-035205.md) | [(17.0) d](/filings/0001437749-26-010362.md) | [340](/filings/0001437749-26-016146.md) | [(190) d](/filings/0001437749-26-028064.md) | [275 d](/filings/0001437749-25-035205.md) | [(355) d](/filings/0001437749-26-010362.md) | [501](/filings/0001437749-26-016146.md) | [(393) d](/filings/0001437749-26-028064.md) | | Capital expenditure | $k | [0.0 d](/filings/0001437749-23-032026.md) | [0.0 d](/filings/0001437749-24-010393.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-010362.md) | not reported | not reported | not reported | [0.0 d](/filings/0001437749-26-010362.md) | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | thousands of shares | [5,355](/filings/0001437749-25-010246.md) | [5,382](/filings/0001437749-25-010246.md) | [5,604](/filings/0001437749-26-010362.md) | [5,483](/filings/0001437749-26-010362.md) | [5,532](/filings/0001437749-26-010362.md) | [5,577](/filings/0001437749-26-010362.md) | [5,353](/filings/0001437749-26-016146.md) | [5,353](/filings/0001437749-26-028064.md) | [5,650](/filings/0001437749-26-010362.md) | [5,548](/filings/0001437749-26-010362.md) | [6,410](/filings/0001437749-26-016146.md) | [6,411](/filings/0001437749-26-028064.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 12,613,149 at 2026-07-31, from the cover of the [10-Q filed 2026-08-14](/filings/0001437749-26-028064.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.